Insider Selling: Phreesia, Inc. (NYSE:PHR) SVP Sells 11,685 Shares of Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) SVP David Linetsky sold 11,685 shares of the stock in a transaction on Monday, January 27th. The shares were sold at an average price of $27.48, for a total transaction of $321,103.80. Following the transaction, the senior vice president now owns 231,271 shares of the company's stock, valued at $6,355,327.08. This trade represents a 4.81 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

David Linetsky also recently made the following trade(s):

• On Wednesday, January 29th, David Linetsky sold 500 shares of Phreesia stock. The shares were sold at an average price of $29.68, for a total transaction of $14,840.00.
• On Wednesday, December 18th, David Linetsky sold 24 shares of Phreesia stock. The shares were sold at an average price of $25.38, for a total transaction of $609.12.
• On Monday, December 16th, David Linetsky sold 35 shares of Phreesia stock. The stock was sold at an average price of $24.88, for a total transaction of $870.80.
• On Wednesday, December 11th, David Linetsky sold 11,853 shares of Phreesia stock. The stock was sold at an average price of $24.85, for a total transaction of $294,547.05.

Phreesia Stock Down 1.8 %

Shares of NYSE:PHR traded down $0.53 during trading on Friday, reaching $28.47. The stock had a trading volume of 306,682 shares, compared to its average volume of 388,179. Phreesia, Inc. has a one year low of $17.07 and a one year high of $29.90. The company has a market capitalization of $1.65 billion, a P/E ratio of -19.37 and a beta of 0.94. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm's 50-day simple moving average is $24.98 and its 200 day simple moving average is $23.28.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million for the quarter, compared to analysts' expectations of $106.33 million. During the same period last year, the business earned ($0.58) EPS. The company's revenue was up 16.6% compared to the same quarter last year. As a group, research analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Institutional Trading of Phreesia

A number of institutional investors have recently modified their holdings of PHR. Hsbc Holdings PLC acquired a new stake in Phreesia in the 2nd quarter worth approximately $301,000. Sei Investments Co. boosted its stake in Phreesia by 135.3% in the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company's stock worth $3,505,000 after purchasing an additional 95,058 shares in the last quarter. Squarepoint Ops LLC boosted its stake in Phreesia by 56.3% in the 2nd quarter. Squarepoint Ops LLC now owns 250,396 shares of the company's stock worth $5,308,000 after purchasing an additional 90,215 shares in the last quarter. SG Americas Securities LLC acquired a new stake in Phreesia in the 3rd quarter worth approximately $954,000. Finally, Diversified Trust Co boosted its stake in Phreesia by 12.9% in the 3rd quarter. Diversified Trust Co now owns 24,356 shares of the company's stock worth $555,000 after purchasing an additional 2,782 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

PHR has been the subject of several analyst reports. Royal Bank of Canada upgraded shares of Phreesia from a "sector perform" rating to an "outperform" rating and raised their target price for the stock from $24.00 to $32.00 in a report on Wednesday, January 8th. JMP Securities restated a "market outperform" rating and issued a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. KeyCorp raised their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock an "overweight" rating in a report on Wednesday, January 8th. Truist Financial raised their price target on shares of Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a research note on Wednesday, December 11th. Finally, Citigroup raised their price target on shares of Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a research note on Friday, January 10th. Thirteen analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $31.15.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.